Miltenyi is one of Europe’s largest biomedical companies providing integrated solutions—from cell isolation and analysis to clinical‑scale manufacturing—that support the entire translational workflow.
The company seeks to empower researchers and clinicians by providing comprehensive platforms—spanning sample preparation, cell separation, flow cytometry, and GMP‑grade cell processing—that facilitate the translation of discoveries into therapies.
Miltenyi prioritizes technological innovation, investing in next‑generation tools that enable deep phenotypic, molecular, and functional insights into complex biological systems.
Its technology development is rooted in precision engineering and evidence‑driven practices, ensuring reliability, reproducibility, and compliance with stringent international standards.
Ultimately, the company’s overarching goal is to advance scientific progress and improve patient outcomes by driving technological leadership across biomedical research and cellular therapy.
Representatives
Scientific Director - Grants and Collaborations @ R&D Department
Miltenyi serves the full ATMP value chain, from enabling technologies and GMP manufacturing platforms to real world clinical deployment.
Partner seeks Consortium/Coordinator
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
Author
Scientific Director - Grants and Collaborations @ R&D Department at Miltenyi Biotec